# Semnur Pharmaceuticals, Inc.: Form 8-K, filed Feb 27, 2024

- Company: [Semnur Pharmaceuticals, Inc.](/companies/smnr.md) (CIK 1913577)
- Form: 8-K
- Filed: 2024-02-27
- Accepted by EDGAR: Feb 27, 2024, 16:30 ET
- Period: 2024-02-22
- Accession: 0001213900-24-017542
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1913577/000121390024017542/ea0200805-8k_denalicap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1913577/000121390024017542/

## Items reported

- Item 3.01: Delisting notice
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1913577/000121390024017542/ea0200805-8k_denalicap.htm

Filed Feb 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-017542. Last ingested by Listed: Nov 4, 2026, 17:17 ET. No prices; not investment advice.